mRNA 疫苗和治疗市场规模、占有率、趋势、行业分析报告（按类型、应用、治疗类型、最终用户和地区）- 市场预测，2025-2034 年

根据 Polaris Market Research 的一项新研究，全球 mRNA 疫苗和治疗市场预计到 2034 年将达到 2,538.3 亿美元。该研究报告对当前市场动态提供了详细的见解，并对未来市场成长进行了分析。

mRNA 疫苗和治疗市场正在迅速发展，尤其是在 COVID-19 疫情爆发之后。信使 RNA (mRNA) 技术已成为 COVID-19 疫苗开发的一种方法，具有前所未有的速度和灵活性。这项创新为大流行期间快速生产疫苗铺平了道路，并为未来针对流感、癌症和爱滋病毒等多种疾病的疫苗和治疗具有巨大潜力。

传统疫苗开发通常需要一个漫长的过程来识别最佳抗原、培养病毒样本并生产大量疫苗。相较之下，mRNA 技术可以快速解码病原体的遗传密码併合成编码所需抗原的 mRNA。这意味着一旦知道基因序列，就可以针对任何传染病快速开发出mRNA疫苗。这种能力促成了对 COVID-19 以外的其他疾病（例如流感和寨卡病毒）的 mRNA 疫苗的研究。

mRNA 疗法正在被探索用于其他用途，特别是在肿瘤学领域。包括 Moderna 和 BioNTech 在内的多家公司已开始对基于 mRNA 的癌症疫苗进行临床试验，并取得了令人欣喜的早期结果。这些疫苗有可能用于治疗多种癌症，既可以作为单一疗法，也可以与化疗或免疫疗法等其他治疗方法合併使用。

mRNA 疫苗和治疗市场报告重点

根据应用，由于 mRNA 技术能够透过开发个人化癌症疫苗和癌症免疫疗法彻底改变癌症治疗，预计肿瘤学领域将在预测期内实现快速成长。

按类型划分，传统的非扩增 mRNA 疫苗部分在 2024 年占据了 mRNA 疫苗和治疗市场的主导占有率，这得益于其在 COVID-19 疫情期间被证明的功效和广泛采用。

在全球市场中，由于强大的医疗保健基础设施、对研发的大量投资以及 mRNA 技术的快速进步，预计北美将在 2024 年占据最大的收入占有率。

全球一些主要的市场参与者包括Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.。

目录

第 1 章简介

第 2 章执行摘要

第 3 章 研究方法

第 4 章。

• 市场概况
• mRNA 疫苗与治疗市场动态
  • 推动因素和机遇
    • 扩大研发、协作和策略伙伴关係 增加对基于 mRNA 的产品的监管批准
  • 阻碍因素和课题
    • 严格的监理标准
• PESTEL 分析
• mRNA 疫苗和疗法的市场趋势
• 价值链分析
• COVID-19 影响分析

第 5 章。

• 主要发现
• 简介
• 自我扩增的 mRNA 疫苗
• 传统非扩增 mRNA 疫苗

6. 全球 mRNA 疫苗和治疗市场（按应用）

• 主要发现
• 简介
• 癌症
• 传染病
• 自体免疫疾病
• 其他

7. 全球 mRNA 疫苗与治疗市场（依治疗类型划分）

• 主要发现
• 简介
• 单株抗体
• 基因治疗
• 细胞疗法
• 其他

8. 全球 mRNA 疫苗和治疗市场（按最终用户划分）

• 主要发现
• 简介
• 调查研究机构
• 医院
• 诊所
• 其他

第 9 章。

• 主要发现
• 简介
  • mRNA 疫苗和治疗市场评估：各地区，2020 年至 2034 年
• 北美洲
  2020 年至 2034 年北美各类型
  • 2020 年至 2034 年北美各应用领域 北美，依治疗类型，2020 年至 2034 年
  • 2020 年至 2034 年，北美地区终端用户分布
  • 美国
  • 加拿大
• 欧洲
  2020 年至 2034 年欧洲各类型 2020 年至 2034 年欧洲应用状况 2020 年至 2034 年欧洲各治疗类型 2020 年至 2034 年欧洲终端用户状况
  • 英国
  • 法国
  • 德国
  • 义大利
  • 西班牙
  • 荷兰
  • 俄罗斯
  • 其他欧洲国家
  亚太地区
  2020 年至 2034 年亚太地区各类产品 2020 年至 2034 年亚太地区应用情况 2020 年至 2034 年亚太地区治疗类型 2020 年至 2034 年亚太地区最终用户状况
  • 中国
  • 印度
  • 马来西亚
  • 日本
  • 印尼
  • 韩国
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲
  2020 年至 2034 年中东和非洲各类型 2020 年至 2034 年中东和非洲的应用状况 中东和非洲：依治疗类型，2020 年至 2034 年 2020 年至 2034 年中东和非洲最终用户状况
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 以色列
  • 南非
  • 其他中东和非洲地区
• 拉丁美洲
  2020 年至 2034 年拉丁美洲各类型
  • 2020 年至 2034 年拉丁美洲各应用领域状况 2020 年至 2034 年拉丁美洲各治疗类型 2020 年至 2034 年拉丁美洲最终用户状况
  • 墨西哥
  • 巴西
  • 阿根廷
  • 其他拉丁美洲国家

第 10 章 竞争格局

• 扩张与收购分析
  • 放大
  • 收购
• 伙伴关係/协作/协定/揭露

第 11 章 公司简介

• Pfizer Inc.
• Moderna, Inc.
• BioNTech SE
• GlaxoSmithKline
• Daiichi Sankyo
• BioNTech SE
• CureVac N.V.
• AstraZeneca
• Ethris
• Sanofi
• Arcturus Therapeutics
• Innovac Therapeutics
• Kernal Biologics
• Pantherna Therapeutics
• Ziphius Vaccines

The global mRNA vaccines and therapeutics market size is expected to reach USD 253.83 billion by 2034, according to a new study by Polaris Market Research. The report "mRNA Vaccines and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Self-Amplifying mRNA-Based Vaccines and Conventional Non-Amplifying mRNA-Based Vaccines), Application, Treatment Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The mRNA vaccines and therapeutics market has seen a rapid evolution, particularly with the emergence of the COVID-19 outbreak. Messenger RNA (mRNA) technology emerged as an approach for COVID-19 vaccine development, offering unprecedented speed and flexibility. This innovation has created the way for rapid vaccine production during the pandemic and holds immense potential for future vaccines and therapeutics for a wide array of diseases such as influenza, cancer, and HIV.

Traditional vaccine development often requires lengthy processes to identify the most suitable antigens, grow virus samples, and produce large quantities of vaccine doses. In contrast, mRNA technology allows for rapid sequencing of a pathogen's genetic code, followed by the synthesis of mRNA that encodes the required antigen. This means that mRNA vaccines can be developed for any infectious disease as soon as its genetic sequence is known. This capability has prompted the exploration of mRNA vaccines for diseases beyond COVID-19, including influenza and Zika virus.

mRNA therapeutics are being explored for other applications, particularly in oncology. Several companies, including Moderna and BioNTech, have begun clinical trials for mRNA-based cancer vaccines, with promising early results. These vaccines may potentially be used to treat a variety of cancers, as standalone therapies or in combination with other treatments such as chemotherapy and immunotherapy.

mRNA Vaccines and Therapeutics Market Report Highlights

In terms of application, the cancer segment is expected to grow at a rapid pace during the forecast period owing to the ability of mRNA technology to revolutionize cancer treatment by enabling the development of personalized cancer vaccines and cancer immunotherapies.

Based on type, the conventional non-amplifying mRNA-based vaccines segment dominated the mRNA vaccines and therapeutics market share in 2024 owing to their proven efficacy and widespread adoption during the COVID-19 outbreak.

In the global market, North America held the largest revenue share in 2024 due to robust healthcare infrastructure, significant investments in research and development, and rapid advancements in mRNA technology.

A few of the global key market players are Pfizer Inc.; Moderna, Inc.; BioNTech SE; GlaxoSmithKline; Daiichi Sankyo; BioNTech SE; CureVac N.V.; AstraZeneca; Ethris; Sanofi; Arcturus Therapeutics; Innovac Therapeutics; Kernal Biologics; Pantherna Therapeutics; pHion Therapeutics; Recode Therapeutics; Rejuvenation Technologies; RNAimmune; Strand Therapeutics; Walvax; and Ziphius Vaccines.

Polaris Market Research has segmented the mRNA vaccines and therapeutics market report on the basis of type, application, treatment type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

• Self-Amplifying mRNA-Based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines

By Application Outlook (Revenue, USD Billion, 2020-2034)

• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Others

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

• Monoclonal Antibody
• Gene Therapy
• Cell Therapy
• Other

By End User Outlook (Revenue, USD Billion, 2020-2034)

• Research Laboratories and Organizations
• Hospitals
• Clinics
• Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Source
  • 3.2.1. Primary Source
  • 3.2.2. Secondary Source

4. Global mRNA Vaccines and Therapeutics Market Insights

• 4.1. mRNA Vaccines and Therapeutics Market - Market Snapshot
• 4.2. mRNA Vaccines and Therapeutics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Research and Development (R&D), Collaborations, and Strategic Partnerships
    • 4.2.1.2. Increased Regulatory Approvals for mRNA-based Products
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Strict regulatory norms
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. mRNA Vaccines and Therapeutics Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global mRNA Vaccines and Therapeutics Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
• 5.3. Self-amplifying mRNA-based Vaccines
  • 5.3.1. Global mRNA Vaccines and Therapeutics Market, by Self-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)
• 5.4. Conventional Non-amplifying mRNA-based Vaccines
  • 5.4.1. Global mRNA Vaccines and Therapeutics Market, by Conventional Non-amplifying mRNA-based Vaccines, by Region, 2020-2034 (USD Billion)

6. Global mRNA Vaccines and Therapeutics Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
• 6.3. Cancer
  • 6.3.1. Global mRNA Vaccines and Therapeutics Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 6.4. Infectious Diseases
  • 6.4.1. Global mRNA Vaccines and Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
• 6.5. Autoimmune Diseases
  • 6.5.1. Global mRNA Vaccines and Therapeutics Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
• 6.6. Others
  • 6.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global mRNA Vaccines and Therapeutics Market, by Treatment Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
• 7.3. Monoclonal Antibody
  • 7.3.1. Global mRNA Vaccines and Therapeutics Market, by Monoclonal Antibody, by Region, 2020-2034 (USD Billion)
• 7.4. Gene Therapy
  • 7.4.1. Global mRNA Vaccines and Therapeutics Market, by Gene Therapy, by Region, 2020-2034 (USD Billion)
• 7.5. Cell Therapy
  • 7.5.1. Global mRNA Vaccines and Therapeutics Market, by Cell Therapy, by Region, 2020-2034 (USD Billion)
• 7.6. Others
  • 7.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global mRNA Vaccines and Therapeutics Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 8.3. Research Laboratories and Organizations
  • 8.3.1. Global mRNA Vaccines and Therapeutics Market, by Research Laboratories and Organizations, by Region, 2020-2034 (USD Billion)
• 8.4. Hospitals
  • 8.4.1. Global mRNA Vaccines and Therapeutics Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 8.5. Clinics
  • 8.5.1. Global mRNA Vaccines and Therapeutics Market, by Clinics, by Region, 2020-2034 (USD Billion)
• 8.6. Others
  • 8.6.1. Global mRNA Vaccines and Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global mRNA Vaccines and Therapeutics Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. mRNA Vaccines and Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. mRNA Vaccines and Therapeutics Market - North America
  • 9.3.1. North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.3.3. North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.3.4. North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.3.5. mRNA Vaccines and Therapeutics Market - US
    • 9.3.5.1. US: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. US: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.3. US: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.3.5.4. US: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.3.6. mRNA Vaccines and Therapeutics Market - Canada
    • 9.3.6.1. Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.4. mRNA Vaccines and Therapeutics Market - Europe
  • 9.4.1. Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.4.3. Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.4.4. Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.5. mRNA Vaccines and Therapeutics Market - UK
    • 9.4.5.1. UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.6. mRNA Vaccines and Therapeutics Market - France
    • 9.4.6.1. France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.3. France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.6.4. France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.7. mRNA Vaccines and Therapeutics Market - Germany
    • 9.4.7.1. Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.8. mRNA Vaccines and Therapeutics Market - Italy
    • 9.4.8.1. Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.9. mRNA Vaccines and Therapeutics Market - Spain
    • 9.4.9.1. Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.10. mRNA Vaccines and Therapeutics Market - Netherlands
    • 9.4.10.1. Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.11. mRNA Vaccines and Therapeutics Market - Russia
    • 9.4.11.1. Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.4.12. mRNA Vaccines and Therapeutics Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.5. mRNA Vaccines and Therapeutics Market - Asia Pacific
  • 9.5.1. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.5. mRNA Vaccines and Therapeutics Market - China
    • 9.5.5.1. China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.3. China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.5.4. China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.6. mRNA Vaccines and Therapeutics Market - India
    • 9.5.6.1. India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.3. India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.6.4. India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.7. mRNA Vaccines and Therapeutics Market - Malaysia
    • 9.5.7.1. Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.8. mRNA Vaccines and Therapeutics Market - Japan
    • 9.5.8.1. Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.9. mRNA Vaccines and Therapeutics Market - Indonesia
    • 9.5.9.1. Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.10. mRNA Vaccines and Therapeutics Market - South Korea
    • 9.5.10.1. South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.11. mRNA Vaccines and Therapeutics Market - Australia
    • 9.5.11.1. Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.5.12. mRNA Vaccines and Therapeutics Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.6. mRNA Vaccines and Therapeutics Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.5. mRNA Vaccines and Therapeutics Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.6. mRNA Vaccines and Therapeutics Market - UAE
    • 9.6.6.1. UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.7. mRNA Vaccines and Therapeutics Market - Israel
    • 9.6.7.1. Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.8. mRNA Vaccines and Therapeutics Market - South Africa
    • 9.6.8.1. South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.6.9. mRNA Vaccines and Therapeutics Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
• 9.7. mRNA Vaccines and Therapeutics Market - Latin America
  • 9.7.1. Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.5. mRNA Vaccines and Therapeutics Market - Mexico
    • 9.7.5.1. Mexico: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.6. mRNA Vaccines and Therapeutics Market - Brazil
    • 9.7.6.1. Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.7. mRNA Vaccines and Therapeutics Market - Argentina
    • 9.7.7.1. Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)
  • 9.7.8. mRNA Vaccines and Therapeutics Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Pfizer Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Moderna, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. BioNTech SE
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. GlaxoSmithKline
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Daiichi Sankyo
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. BioNTech SE
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. CureVac N.V.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. AstraZeneca
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Ethris
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Sanofi
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Arcturus Therapeutics
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Innovac Therapeutics
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Kernal Biologics
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Pantherna Therapeutics
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Ziphius Vaccines
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development

List of Tables:

Table 1 Global mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 2 Global mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 3 Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 4 Global mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 5 North America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 7 North America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 8 North America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 9 U.S.: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 11 U.S.: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 12 U.S.: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 13 Canada: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 15 Canada: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 16 Canada: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 17 Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 19 Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 20 Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 21 UK: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 23 UK: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 24 UK: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 25 France: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 26 France: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 27 France: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 28 France: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 29 Germany: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 31 Germany: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 32 Germany: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 33 Italy: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 35 Italy: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 36 Italy: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 37 Spain: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 39 Spain: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 40 Spain: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 41 Netherlands: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 43 Netherlands: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 44 Netherlands: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 45 Russia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 47 Russia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 48 Russia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 51 Rest of Europe: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 52 Rest of Europe: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 55 Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 56 Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 57 China: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 58 China: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 59 China: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 60 China: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 61 India: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 62 India: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 63 India: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 64 India: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 65 Malaysia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 67 Malaysia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 68 Malaysia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 69 Japan: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 71 Japan: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 72 Japan: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 73 Indonesia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 75 Indonesia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 76 Indonesia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 77 South Korea: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 79 South Korea: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 80 South Korea: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 81 Australia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 83 Australia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 84 Australia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 97 UAE: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 99 UAE: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 100 UAE: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 101 Israel: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 103 Israel: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 104 Israel: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 105 South Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 107 South Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 108 South Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 113 Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 115 Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 116 Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 117 Mexico: mRNA vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: mRNA vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 119 Mexico: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 120 Mexico: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 121 Brazil: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 123 Brazil: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 124 Brazil: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 125 Argentina: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 127 Argentina: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 128 Argentina: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Application, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by Treatment Type, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: mRNA Vaccines and Therapeutics Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global mRNA Vaccines and Therapeutics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global mRNA Vaccines and Therapeutics Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global mRNA Vaccines and Therapeutics Market, by Application, 2024 & 2034 (USD Billion)

Figure 10. Market by Treatment Type

Figure 11. Global mRNA Vaccines and Therapeutics Market, by Treatment Type, 2024 & 2034 (USD Billion)

Figure 12. Market by End User

Figure 13. Global mRNA Vaccines and Therapeutics Market, by End User, 2024 & 2034 (USD Billion)